Klinik Kullanım İçin Mezenkimal Kök Hücrelerin Hazırlanması
Mezenkimal kök hücreler MKH kendini yenileme potansiyeli olan, osteoblast, kondrosit ve adiposit gibi özelleşmiş hücrelere farklılaşabilme yeteneğine sahip, erişkin, multipotent hücrelerdir. Klinikte kullanılmaları için özel üretim koşulları gerekmektedir. GMP Good Manufacturing Practice- İyi Üretim Uygulamaları şartlarında hücre üretimi, temel kök hücre bilimlerinden klinik araştırmalara ve uygulamalara translasyon için yüksek bir kalite güvence sistemi sağlar. Üretim protokolünde kullanılan enzim içeriği ve konsantrasyonu, parçalanma süresi, santrifüj hız farklılıkları, filtre boyutu gibi değişkenler, MKH eldesindeki farklılıkları oluşturur. Uygun üretim, doz ve uygulama yolu standardize edilerek hastada en başarılı tedavi sonucuna ulaşılır. Derlemede, MKH' lerin özelliklerini ve klinikte kullanımlarına özgü olarak nasıl hazırlandıklarını ve hazırlanma esnasındaki değişkenlerin hücre üzerine etkilerini açıklanması amaçlanmıştır
Mesenchymal Stem Cell Production for Clinical Usage
Mesenchymal stem cells MSC are multipotent cells that can differentiate into specialized cells such as osteoblasts, chondrocytes and adipocytes, and have the ability for self-renewal. However, special production conditions are required for clinical usage. GMP Good Manufacturing Practice Laboratory conditions may provide a high quality control system in translational medicine from basic stem cell research to clinical trials. The content and concentration of the enzyme, digestion period, the speed of the centrifuge and filter size may be among the variables that affect the characteristics of MSCs. The production methods, application and dose of MSCs for certain therapies should therefore be standardized according to the best clinical treatment available for the patient. The aim of this review is to explain the characteristics of MSCs, the special production methods for their use in clinical practice, and their effects on various cells
___
- 1. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach
I, Marini F, Krause D, Deans R, Keating A, Prockop
D, Horwitz E. Minimal criteria for defining multipotent
mesenchymal stromal cells. The International Society for
Cellular Therapy position statement. Cytotherapy 2006;
8:315-17.
- 2. Pendleton C, Li Q, Chesler DA, Yuan K, GuerreroCazares H, Quinones-Hinojosa A. Mesenchymal stem
cells derived from adipose tissue vs bone marrow: In vitro
comparison of their tropism towards gliomas. PLoS One
2013;8:581-98.
- 3. Thirumala S, Goebel WS, Woods EJ. Clinical grade adult
stem cell banking. Organogenesis 2009;5:143-54.
- 4. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK,
Douglas R, Mosca JD, Moorman MA, Simonetti DW,
Craig S, Marshak DR. Multilineage potential of adult
human mesenchymal stem cells. Science 1999; 284:143-7.
- 5. Li H, Ghazanfari R, Zacharaki D, Lim HC, Scheding S.
Isolation and characterization of primary bone marrow
mesenchymal stromal cells. Ann NY Acad Sci 2016;
1370:109-18.
- 6. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz
AJ, Benhaim P, Lorenz HP, Hedrick MH. Multilineage
cells from human adipose tissue: Implications for cellbased therapies. Tissue Eng 2001;7(2):211-28.
- 7. Kolaparthy LK, Sanivarapu S, Moogla S, Kutcham RS.
Adipose tissue-adequate, accessible regenerative material.
Int J Stem Cells 2015;8:121-7.
- 8. Bersenev A. Cell therapy clinical trials-2014 report. Cell
Trials Blog, 2015.
- 9. Fellows CR, Matta C, Zakany R, Khan İM, Mobasheri
A. Adipose, bone marrow and synovial joint-derived
mesenchymal stem cells for cartilage repair. Front Genet
2016;7:213.
- 10. Tatullo M, Codispoti B, Pacifici A, Palmieri F, Marrelli M,
Pacifici L, Paduano F. Potential use of human periapical
cyst-mesenchymal stem cells (hPCy-MSCs) as a novel
stem cell source for regenerative medicine applications.
Front Cell Dev Biol 2017;5:103.
- 11. Mobasheri A, Kalamegam G, Musumeci G, Batt ME.
Maturitas chondrocyte and mesenchymal stem cell-based
therapies for cartilage repair in osteoarthritis and related
orthopaedic conditions 2014; 78(3):188-98.
- 12. Sellam J, Berenbaum F. The role of synovitis in
pathophysiology and clinical symptoms of osteoarthritis.
Nat Rev Rheumatology 2010; 6(11):625-35.
- 13. Gronthos S, Mankani M, Brahim J, Robey PG, Shi S.
Postnatal human dental pulp stem cells (DPSCs) in vitro
and in vivo. Proc Natl Acad Sci USA 2000;97(25):13625
30.
- 14. Alsalameh S, Amin R, Gemba T, Lotz M. Identification of
mesenchymal progenitor cells in normal and osteoarthritic
human articular cartilage. Rheum A 2004; 50 (5):1522-32.
- 15. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, Park
TS, Andriolo G, Sun B, Zheng B, Zhang L, Norotte C,
Teng PN, Traas J, Schugar R, Deasy BM, Badylak S,
Buhring HJ, Giacobino JP, Lazzari L, Huard J, Péault B.A
perivascular origin for mesenchymal stem cells in multiple
human organs. Cell Stem Cell 2008;3(3):301-13.
- 16. Wagner W, Wein F, Seckinger A, Frankhauser M,
Wirkner U, Krause U, Blake J, Schwager C, Eckstein V,
Ansorge W. Comparative characteristics of mesenchymal
stem cells from human bone marrow, adipose tissue, and
umbilical cord blood. Exp Hematol 2005;33:1402-16.
- 17. Ozbey O, Sahin Z, Acar N, Ozcelik FT, Ozenci AM,
Koksoy S, Ustunel I. Characterization of colony-forming
cells in adult human articular cartilage. Acta Histochem
2014;116(5):763-70.
- 18. Ustunel I, Ozenci AM, Sahin Z, Ozbey O, Acar
N, Tanriover G, Celik-Ozenci C, Demir R. The
immunohistochemical localization of notch receptors and
ligands in human articular cartilage, chondroprogenitor
culture and ultrastructural characteristics of these
progenitor cells. Acta Histochem 2008;110(5):397-07.
- 19. Baglioni S, Francalanci M, Squecco R, Lombardi A,
Cantini G, Angeli R, Gelmini S, Guasti D, Benvenuti S,
Annunziato F. Characterization of human adult stemcell populations isolated from visceral and subcutaneous
adipose tissue. FASEB J 2009; 23:3494-05.
- 20. Türkiye İlaç ve Tıbbi Cihaz Kurumundan: İnsan
Doku ve Hücre Ürünlerinin Ruhsatlandırılması ve bu
Ürünlerin Üretim, İthalat, İhracat, Depolama ve Dağıtım
Faaliyetlerini Yürüten Merkezler hakkında Tebliğ. 4
Nisan 2014 Resmi gazete sayı: 28962.
- 21. Türkiye İlaç ve Tıbbi Cihaz Kurumundan: İnsan Doku
ve Hücreleri İle Bunlarla İlgili Merkezlerin Kalite ve
Güvenliği Hakkında Yönetmelik 27 Ekim 2010 Resmi
Gazete sayı: 27742.
- 22. Shi YY, Nacamuli RP, Salim A, Longaker MT. The
osteogenic potential of adipose derived mesenchymal
cells is maintained with aging. Plast Reconstr Surg 2005;
116:1686-96.
- 23. Baksh D, Yao R, Tuan RS. Comparison of proliferative
and multilineage differentiation potential of human
mesenchymal stem cells derived from umbilical cord and
bone marrow. Stem Cells 2007;25:1384-92.
- 24. Rebelatto CK, Aguiar AM, Moretão MP, Senegaglia AC,
Hansen P, Barchiki F, Oliveira J, Martins J, Kuligovski
C, Mansur F, Christofis A, Amaral VF, Brofman
PS, Goldenberg S, Nakao LS, Correa A. Dissimilar
differentiation of mesenchymal stem cells from bone
marrow, umbilical cord blood, and adipose tissue. Exp
Biol Med (Maywood) 2008;233:901-13.
- 25. Baer PC, Geiger H. Adipose-derived mesenchymal
stromal/stem cells: tissue localization, characterization,
and heterogeneity. Stem Cells Int 2012;812693.
- 26. Zhu Y, Liu T, Song K, Fan X, Ma X, Cui Z. Adiposederived stem cell: A better stem cell than BMSC. Cell
Biochem Funct 2008;26:664-75.
- 27. Smith RJ,Pfeifer K, Petry F,Powell N,Delzeit J,Weiss M.
Standardizing umbilical cord mesenchymal stromal cells
for translation to clinical use: Selection of GMP-compliant
medium and a simplified isolation method. Stem Cells Int
2016; 6810980.
- 28. Atala A. Methods of Tissue Engineering. Houston, Texas:
Gulf Professional Publishing; 2002.
- 29. Salehinejad P, Alitheen NB, Ali AM, Omar AR, Mohit
M, Janzamin E, Samani FS, Torshizi Z, NematollahiMahani SN. Comparison of different methods for the
isolation of mesenchymal stem cells from human umbilical
cord Wharton’s jelly In Vitro Cell. Dev Biol Anim 2012;
48:75-83.
- 30. Yoon JH, Roh EY, Shin S, Jung NH, Song EY, Chang JY,
Kim BJ, Jeon HW. Comparison of explant-derived and
enzymatic digestion-derived MSCs and the growth factors
from Wharton’s jelly. Biomed Res Int 2013;428726.
- 31. Hilkens P, Gervois P, Fanton Y, Vanormelingen J,
Martens W, Struys T, Politis C, Lambrichts I, Bronckaers
A. Effect of isolation methodology on stem cell properties
and multilineage differentiation potential of human dental
pulp stem cells. Cell Tissue Res 2013; 353:65-78.
- 32. Hendijani F. Explant culture: An advantageous method
for isolation of mesenchymal stem cells from human
tissues. Cell Prolif 2017;50:12334.
- 33. Hynes RO. The extracellular matrix: Not just pretty
fibrils. Science 2009;326:1216-19.
- 34. Raposio E, Simonacci F, Perrotta RE. Adipose-derived
stem cells: Comparison between two methods of isolation
for clinical applications. Ann Med Surg (Lond) 2017;20:
87-91.
- 35. Lazzina R, Mariotti A, Procoli A, Fioravanti D, Iudicone
P, Scambia G, Pierelli L, Bonanno G. A new standardized
clinical-grade protocol for banking human umbilical cord
tissue cells. Transplantation and Cellular Engineerıng
2015;55(12):2864-73.
- 36. Jurgens WJ, Oedayrajsingh-Varma MJ, Helder MN,
Zandiehdoulabi B, Schouten TE, Kuik DJ, Ritt MJ, van
Milligen FJ. Effect of tissue-harvesting site on yield of stem
cells derived from adipose tissue: Implications for cellbased therapies. Cell Tissue Res 2008;332:415-26.
- 37. Heiskanen A, Satomaa T, Tiitinen S, Laitinen A,
Mannelin S, Impola U, Mikkola M, Olsson C, MillerPodraza H, Blomqvist M, Olonen A, Salo H, Lehenkari
P, Tuuri T, Otonkoski T, Natunen J, Saarinen J, Laine
J. N-glycolylneuraminic acid xenoantigen contamination
of human embryonic and mesenchymal stem cells is
substantially reversible. Stem Cells 2007;25:197-202.
- 38. Sundin M, Ringd O, Sundberg B, Nava S,
Geotherstreom C, Le Blanc K. No alloantibodies against
mesenchymal stromal cells, but presence of anti-fetal
calf serum antibodies, after transplantation in allogeneic
hematopoietic stem cell recipients. Haematologica 2007;
92:1208-15.
- 39. Dimarakis I, Levicar N. Cell culture medium composition
and translational adult bone marrow-derived stem cell
research. Stem Cells 2006;24:1407-08.
- 40. Doucet C, Ernou I, Zhang Y, Llense JR, Begot L, Holy
X, Lataillade JJ. Platelet lysates promote mesenchymal
stem cell expansion: a safety substitute for animal serum
in cell-based therapy applications. J Cell Physiology 2005;
205(2):228-36.
- 41. Müller I, Kordowich S, Holzwarth C, Spano C, Isensee
G, Staiber A, Viebahn S, Gieseke F, Langer H, Gawaz
MP, Horwitz EM, Conte P, Handgretinger R, Dominici
M. Animal serum-free culture conditions for isolation and
expansion of multipotent mesenchymal stromal cells from
human BM. Cytotherapy 2006;8(5):437-44.
- 42. Bartmann C, Rohde E, Schallmoser K, Purstner P,
Lanzer G, Linkesch W, Strunk D. Two steps to functional
mesenchymal stromal cells for clinical application.
Transfusion 2007;47(8):1426-35.
- 43. Bieback K, Hecker A, Kocaomer A, Lannert H,
Schallmoser K, Strunk D, Klüter H. Human alternatives
to fetal bovine serum for the expansion of mesenchymal
stromal cells from bone marrow. Stem Cells 2009;
27(9):2331-41.
- 44. Fekete N, Rojewski MT, Furst D, Kreja L, Ignatius A,
Dausend J, Schrezenmeier H. GMP-compliant isolation
and large-scale expansion of bone marrow-derived MSC.
PLoS One 2012;7(8)43255.
- 45. Bernardo ME, Avanzini MA, Perotti C. Optimization of
in vitro expansion of human multipotent mesenchymal
stromal cells for cell-therapy approaches: Further insights
in the search for a fetal calf serum substitute. J Cell Physiol
2007;211:121-30.
- 46. Sotiropoulou PA, Perez SA, Salagianni M.
Characterization of the optimal culture conditions for
clinical scale production of human mesenchymal stem
cells. Stem Cells 2006;24:462-71.
- 47. Both SK, Muijsenberg AJ, Blitterswijk CA. A rapid and
efficient method for expansion of human mesenchymal
stem cells. Tissue Eng 2007;13:3-9.
- 48. Tsutsumi S, Shimazu A, Miyazaki K. Retention of
multilineage differentiation potential of mesenchymal
cells during proliferation in response to FGF. Biochem
Biophys Res Commun 2001;288:413-19.
- 49. Solchaga LA, Penick K, Porter JD. FGF-2 enhances the
mitotic and chondrogenic potentials of human adult bone
marrow-derived mesenchymal stem cells. J Cell Physiol
2005;203:398-409.
- 50. Martin I, Muraglia A, Campanile G. Fibroblast growth
factor-2 supports ex vivo expansion and maintenance
of osteogenic precursors from human bone marrow.
Endocrinology 1997;138:4456-62.
- 51. Bianchi G, Banfi A, Mastrogiacomo M. Ex vivo
enrichment of mesenchymal cell progenitors by fibroblast
growth factor 2. Exp Cell Res 2003;287:98-105.
- 52. Gharibi B, Hughes F. Effects of medium supplements
on proliferation, differentiation potential, and in vitro
expansion of mesenchymal stem cells. Stem Cells
Translasyonel Medicine 2012;1(11):771-82.
- 53. Sanchez-Guijo F, Caballero-Velazquez T, Lopez-Villar
O, Redondo A, Parody R, Martinez C, Olavarría E,
Andreu E, Prósper F, Díez-Campelo M, Regidor C,
Villaron E, López-Corral L, Caballero D, Cañizo MC,
Pérez-Simon JA. Sequential third-party mesenchymal
stromal cell therapy for refractory acute graft-versushost disease. Biol Blood Marrow Transplant 2014;
20(10):1580-5.
- 54. Astori G, Amati E, Bambi F, Bernardi M, Chieregato
K, Schäfer R, Sella S, Rodeghiero F. Platelet lysate as
a substitute for animal serum for the ex-vivo expansion
of mesenchymal stem/stromal cells: Present and future.
Stem Cell Res Ther 2016;7:93.
- 55. Chase LG, Lakshmipathy U, Solchaga LA, Rao MS,
Vemuri MC. A novel serum-free medium for the
expansion of human mesenchymal stem cells. Stem Cell
Res Ther 2010;21-8.
- 56. Hudson JE, Mills RJ, Frith JE, Brooke G, JaramilloFerrada P, Wolvetang EJ, Cooper-White JJ. A defined
medium and substrate for expansion of human
mesenchymal stromal cell progenitors that enriches for
osteo- and chondrogenic precursors. Stem Cells Dev
2011;20:77-87.
- 57. Song L, Webb NE, Song Y, Tuan RS. Identification
and functional analysis of candidate genes regulating
mesenchymal stem cell self-renewal and multipotency.
Stem Cells 2006;24:1707-18.
- 58. Neth P, Ciccarella M, Egea V, Hoelters J, Jochum M, Ries
C. Wnt signaling regulates the invasion capacity of human
mesenchymal stem cells. Stem Cells 2006;24:1892-103.
- 59. Ren G, Zhang L, Zhao X, Xu G, Zhang Y, Roberts
AI, Zhao RC, Shi Y. Mesenchymal stem cell-mediated
immunosuppression occurs via concerted action of
chemokines and nitric oxide cell. Stem Cell 2008;2:141-
50.
- 60. Marquez-Curtis LA, Janowska-Wieczorek A, McGann
LE, Elliott JA. Mesenchymal stromal cells derived from
various tissues: Biological, clinical and cryopreservation
aspects. Cryobiology 2015;71(2):181-97.
- 61. Roy S, Arora S, Kumari P, Ta M. A simple and serumfree protocol for cryopreservation of human umbilical
cord as source of Wharton’s jelly mesenchymal stem cell.
Cryobiology 2014;68(3):467-72.
- 62. Yuan Z, Lourenco S, Sage EK, Kolluri K, Lowdell M,
Janes SM. Cryopreservation of human mesenchymal
stromal cells expressing TRAIL for human anti-cancer
therapy. Cytotherapy 2016;18(7):860-9.
- 63. Miyamoto Y, Oishi K, Yukawa H, Noguchi H, Sasaki M,
Iwata H, Hayashi S. Cryopreservation of human adipose
tissue-derived stem/progenitor cells using the silk protein
sericin. Cell Transplant 2012;21(2-3):617-22.
- 64. Al-Saqi SH, Saliem M, Quezada HC, Ekblad A, Jonasson
AF, Hovatta O, Götherström C. Defined serum- and
xeno-free cryopreservation of mesenchymal stem cells.
Cell Tissue Bank 2015;16(2):181-93.
- 65. Chatzistamatiou T, Papassavas A, Michalopoulos E,
Gamaloutsos C, Mallis P, Gontika I, Panagouli E,
Koussoulakos S, Stavropoulos-Giokas C. Optimizing
isolation culture and freezing methods to preserve
Wharton’s jelly’s mesenchymal stem cell (MSC)
properties: an MSC banking protocol validation for the
Hellenic Cord Blood Bank. Transplantation and Cellular
Engineering 2014;54(12):3108-20.
- 66. Dragoo JL, Choi JY, Lieberman JR, Huang J, Zuk PA,
Zhang J, Hedrick MH, Benhaim P. Bone induction by
BMP-2 transduced stem cells derived from human fat. J
Orthop Res 2003;21:622-9.
- 67. Galie M, Pignatti M, Scambi I, Sbarbati A, Rigotti G.
Comparison of different centrifugation protocols for
the best yield of adipose-derived stromal cells from
lipoaspirates. Plast Reconstr Surg 2008;122:233-4.
- 68. Kim WS, Park BS, Sung JH. Protective role of adiposederived stem cells and their soluble factors in photoaging.
Arch Dermatol Res 2009;301:329-36